European Pharmaceutical Review

JULY 28, 2023

A research paper has reported a practical framework suitable for a systematic step-by-step quality by design (QbD) approach for the pharmaceutical development of bilayer tablets. According to the authors, bilayer tablets have been considered one of the best options for the development of fixed-dose combination (FDC) formulations.

Dosage 97

Dosage 97

Pharma Pathway

SEPTEMBER 25, 2022

Lupin Limited – Openings for PDL (Process Development Lab) & Packaging Development Department -Apply Now. We have Urgent Requirement for PDL (Process Development Lab) & Packaging Development Department for our Pithampur Location. Department: PDL (Process Development Lab) & Packaging Development.

Packaging 40

Packaging Dosage 40

European Pharmaceutical Review

JULY 20, 2023

Therefore, “a scalable digital twin is useful for operator training, process design under the regulatory demanded quality by design (QbD) approach for risk analysis, design and control space definition and predictive maintenance”. A model was developed from flow and coalescence models. How was the PAT study performed?

60

60

Pharma Pathway

FEBRUARY 2, 2023

In the API segment, we have capabilities to develop and manufacturing products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. Experience in DOE/QbD based development, data compilation and interpretation for regulated markets. Greetings from Natco Pharma Limited !!

Dosage 59

Dosage Documentation Communication Pharmaceutical Companies 59

European Pharmaceutical Review

NOVEMBER 16, 2022

As the emphasis of new drug development gravitates towards new, ground-breaking therapies and vaccines, the requirements of manufacturing sites, equipment and processes need to be appropriate for this new environment.

Documentation 111

Documentation Vaccines Drug Development 111

European Pharmaceutical Review

SEPTEMBER 20, 2023

Although this evolution has led to life-changing medications, it also calls on drug development and manufacturing experts to identify new, more efficient ways to deliver high‑quality products. Pharmaceutical development is driven by quality by design (QbD) – an approach recommended by regulatory agencies.

Drug Development 81

Drug Development 81

European Pharmaceutical Review

MARCH 1, 2023

Importance of CT in pharmacy Industrial CT is an established method for reliable product and process development, process monitoring and requalification. While traditional optical methods can only assess the surface, X-ray technology can be used to display the internal structure, and thus may detect defects and deviations in geometry.

Dosage 82

Dosage 82

Pharmaceutical Technology

JULY 18, 2022

With the ever-rising costs of bringing a drug to market, pharmaceutical companies are increasingly looking at how they can improve the efficiency of their entire product development and drug commercialisation process. There is a risk for variation between batches.”.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Dosage Communication 52

European Pharmaceutical Review

NOVEMBER 9, 2022

Traditionally, companies have sought to outsource the development and manufacture of vectors to a contract development and manufacturing organisation (CDMO). To integrate vector supply, upfront challenges and costs include developing a scalable process and setting up a good manufacturing practice (GMP) manufacturing facility.

Vaccines 95

Vaccines Documentation Communication Hospitals 95

Pharmaceutical Technology

JANUARY 6, 2023

It requires having access to proper techniques and skill sets, state-of-the-art equipment, process scientists and engineers who have a deep understanding of Quality by Design (QbD) principles, and methods for product and process characterisation. Optimising development and scale-up. Particle distribution. Grittiness.

Dosage 52

Dosage Packaging Communication 52